<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupKathryn Alsop, Gillian Mitchell, Sián Fereday et al.|Journal of Clinical Oncology|2012Cited by 1.2k
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G.W. Verhaak, Matthew Meyerson, Pablo Tamayo et al.|Journal of Clinical Investigation|2012Cited by 591
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian CancersÅslaug Helland, David D.L. Bowtell, Michael S. Anglesio et al.|PLoS ONE|2011Cited by 219
Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment OutcomeZhigang C. Wang, Nicolai J. Birkbak, Aedín C. Culhane et al.|Clinical Cancer Research|2012Cited by 162
Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with <i>BRCA1</i> and <i>BRCA2</i> MutationsJoshy George, David D.L. Bowtell, Kathryn Alsop et al.|Clinical Cancer Research|2013Cited by 90